Weighted prevalence rates (95% CI) of tobacco use by male and female students and WHO regions among medical, dental, nursing and pharmacy students
| Current smoking | Current other tobacco use | |||||
| Total | Girls | Boys | Total | Girls | Boys | |
| Medicine* | Medicine | |||||
| AFRO | 8.2 (6.3 to 12.5) | 5.0 (3.3 to 8.6) | 12.3 (10.6 to 19.8) | 3.9 (3.0 to 5.1) | 2.8 (1.8 to 4.4) | 6.2 (4.6 to 8.2) |
| EMRO | 9.9 (8.8 to 11.4) | 2.9 (2.3 to 4.0) | 20.5 (18.2 to 23.4) | 10.2 (9.1 to 11.4) | 4.8 (4.0 to 5.8) | 18.0 (15.2 to 20.3) |
| EURO | 29.2 (26.9 to 32.2) | 25.2 (22.7 to 26.8) | 36.0 (31.7 to 40.0)† | 12.6 (10.8 to 16.9) | 9.1 (7.1 to 12.3) | 18.9 (15.4 to 24.1) |
| AMRO | 20.3 (17.0 to 23.8) | 18.5 (14.7 to 22.6) | 22.7 (18.4 to 27.4)† | 7.8 (5.8 to 10.6) | 4.3 (2.8 to 6.9) | 11.6 (8.4 to 16.2)† |
| SEARO | 12.8 (9.6 to 16.8) | 0.3 (0.2 to 0.5) | 18.4 (13.7 to 24.3) | 9.6 (6.3 to 14.6) | 5.9 (2.5 to 13.0) | 11.9 (7.9 to 17.8)† |
| WPRO | 12.8 (10.9 to 14.9) | 3.1 (2.0 to 5.4) | 20.9 (18.6 to 23.5) | 3.8 (2.9 to 5.1) | 1.4 (1.0 to 2.2) | 5.6 (4.3 to 7.5) |
| Dentistry* | Dentistry | |||||
| AFRO | 6.5 (8.8 to 15.3) | 2.6 (2.8 to 8.6) | 12.2 (16.4 to 29.3) | 4.8 (2.7 to 8.6) | 4.4 (1.9 to 9.6) | 6.0 (4.0 to 9.0) |
| EMRO | 13.0 (10.6 to 15.8) | 5.8 (4.0 to 8.6) | 23.8 (19.1 to 29.5) | 14.8 (12.3 to 17.6) | 8.5 (6.3 to 11.7) | 23.4 (19.0 to 28.7) |
| EURO | 40.2 (37.4 to 43.1) | 35.2 (31.5 to 39.3) | 47.2 (39.6 to 55.6)† | 13.1 (10.9 to 17.2) | 8.5 (6.2 to 13.8) | 21.0 (17.3 to 26.6) |
| AMRO | 23.1 (19.8 to 27.3) | 21.9 (18.3 to 26.5) | 26.5 (21.5 to 33.7)† | 9.3 (7.2 to 12.0) | 8.4 (6.1 to 11.8) | 10.7 (6.5 to 18.9)† |
| SEARO | 9.5 (7.1 to 13.0) | 0.1 (0.0 to 0.1) | 23.4 (17.5 to 31.5) | 9.0 (6.3 to 12.9) | 4.6 (2.7 to 8.8) | 16.8 (12.8 to 21.8) |
| WPRO | 8.4 (3.5 to 8.9) | 7.1 (3.8 to 4.6) | 11.0 (1.9 to 6.8)† | 5.4 (1.8 to 8.2) | 7.3 (4.5 to 11.0) | 2.5 (0.8 to 1.3) |
| Nursing* | Nursing* | |||||
| AFRO | 5.2 (4.1 to 6.7) | 1.8 (1.5 to 4.7) | 10.2 (8.4 to 17.4) | 3.1 (2.2 to 4.5) | 2.1 (1.3 to 3.7) | 5.9 (3.7 to 9.9) |
| EMRO | 12.1 (9.4 to 11.5) | 4.6 (3.8 to 5.8) | 27.7 (21.3 to 29.1) | 23.8 (18.1 to 22.8) | 6.8 (5.6 to 8.4) | 27.2 (20.6 to 32.0) |
| EURO | 28.3 (24.5 to 31.6) | 27.5 (23.8 to 31.1) | 34.3 (24.2 to 42.9)† | 7.1 (9.3 to 14.1) | 6.8 (8.7 to 14.0) | 10.9 (9.8 to 23.6)† |
| AMRO | 15.2 (13.4 to 18.6) | 14.3 (12.6 to 17.8) | 20.0 (14.1 to 27.8)† | 6.1 (4.5 to 9.1) | 6.3 (4.7 to 9.5) | 4.8 (1.8 to 10.8)† |
| SEARO | 3.3 (2.0 to 5.4) | 0.1 (0.1 to 0.2) | 21.8 (13.2 to 35.1) | 4.7 (3.4 to 6.7) | 3.4 (2.1 to 6.1) | 15.2 (9.0 to 25.1) |
| WPRO | 5.0 (3.7 to 7.1) | 3.2 (2.9 to 4.6) | 15.0 (7.8 to 31.6) | 3.1 (1.6 to 7.0) | 2.2 (1.2 to 4.1) | 15.1 (6.1 to 33.7) |
| Pharmacy* | Pharmacy* | |||||
| AFRO | 6.0 (4.4 to 8.6) | 2.5 (1.9 to 5.5) | 10.8 (8.2 to 15.2) | 1.6 (1.2 to 2.1) | 0.6 (0.4 to 1.0) | 3.5 (2.8 to 4.5) |
| EMRO | 12.4 (10.4 to 14.9) | 3.4 (2.5 to 4.4) | 26.3 (22.3 to 31.4) | 12.7 (10.7 to 15.2) | 6.6 (5.1 to 8.4) | 21.6 (18.1 to 26.1) |
| EURO | 38.4 (33.9 to 43.0) | 34.2 (29.4 to 39.3) | 55.8 (45.6 to 65.0) | 11.7 (9.4 to 15.6) | 7.3 (5.7 to 11.4) | 28.9 (20.7 to 39.4) |
| AMRO | 12.8 (10.1 to 16.1) | 9.7 (7.1 to 13.6) | 19.0 (14.0 to 26.1)† | 12.1 (9.4 to 15.7) | 10.3 (7.2 to 14.5) | 16.1 (11.0 to 23.1)† |
| SEARO | 12.9 (10.5 to 15.7) | 1.1 (0.7 to 1.4) | 21.1 (17.4 to 25.7) | 9.8 (8.0 to 11.8) | 7.5 (4.7 to 11.7) | 11.3 (8.6 to 15.8)† |
| WPRO | 19.9 (14.5 to 25.8) | 14.9 (12.1 to 23.5) | 35.5 (24.4 to 46.8) | 3.5 (2.1 to 5.8) | 2.9 (1.5 to 5.3) | 2.0 (0.6 to 5.6)† |
*For these the comparisons between six WHO regions (χ2 test) was significant, p<0.05.
†For these comparisons between male and female students (χ2 test) was not significant, p>0.05.